ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
-7.41%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$494M
AUM Growth
+$494M
(-12%)
Cap. Flow
+$4.89M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
58.91%
Holding
49
New
5
Increased
18
Reduced
13
Closed
10
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$20.8M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$20M |
| 3 |
Ascendis Pharma
ASND
|
$10.1M |
| 4 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
$8.21M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$8.13M |
Top Sells
| 1 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$20.2M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$17.7M |
| 3 |
Sarepta Therapeutics
SRPT
|
$9.86M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$7.92M |
| 5 |
Vanda Pharmaceuticals
VNDA
|
$7.12M |
Sector Composition
| 1 | Healthcare | 81.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Acadia Pharmaceuticals
ACAD
$4.38B
| $42.9M | 8.66% | 1,486,460 +693,961 | +88% | +$20M |
|
|
IMMU
2
DELISTED
Immunomedics Inc
IMMU
| $34M | 6.87% | 9,263,340 +1,919,163 | +26% | +$7.04M |
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $33.1M | 6.69% | 400,000 -19,712 | -5% | -$1.63M |
|
4
Iovance Biotherapeutics
IOVA
$807M
| $31.4M | 6.35% | 4,520,643 +263,296 | +6% | +$1.83M |
|
|
TSRO
5
DELISTED
TESARO, Inc.
TSRO
| $31.2M | 6.29% | 231,700 -46,003 | -17% | -$6.19M |
|
|
6
Sarepta Therapeutics
SRPT
$1.78B
| $27.7M | 5.6% | 1,010,300 -359,609 | -26% | -$9.86M |
|
|
NDRM
7
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $23.5M | 4.74% | 1,056,303 +370,000 | +54% | +$8.21M |
|
|
DERM
8
DELISTED
Dermira, Inc.
DERM
| $23.2M | 4.69% | 765,709 -40,217 | -5% | -$1.22M |
|
|
AERI
9
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $23.1M | 4.66% | 610,000 +110,000 | +22% | +$4.16M |
|
10
Neurocrine Biosciences
NBIX
$13.8B
| $20.9M | 4.23% | 541,000 +50,418 | +10% | +$1.95M |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $20.8M | 4.2% | +170,000 | New | +$20.8M |
|
12
Amicus Therapeutics
FOLD
$2.34B
| $20M | 4.03% | 4,017,577 +327,720 | +9% | +$1.63M |
|
13
Bristol-Myers Squibb
BMY
$96B
| $16.7M | 3.36% | 285,000 -114,875 | -29% | -$6.71M |
|
|
SGEN
14
DELISTED
Seagen Inc. Common Stock
SGEN
| $15.6M | 3.15% | 295,533 +154,033 | +109% | +$8.13M |
|
|
AGEN
15
Agenus
AGEN
$133M
| $15.5M | 3.12% | 3,750,430 +34,492 | +0.9% | +$142K |
|
|
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $14.4M | 2.91% | 995,838 +126,575 | +15% | +$1.83M |
|
|
17
Ascendis Pharma
ASND
$11.8B
| $11M | 2.23% | 545,203 +500,000 | +1,106% | +$10.1M |
|
|
TLGT
18
DELISTED
Teligent, Inc
TLGT
| $11M | 2.22% | 1,663,619 +25,800 | +2% | +$171K |
|
19
BioCryst Pharmaceuticals
BCRX
$1.74B
| $10.3M | 2.09% | 1,631,502 +252,100 | +18% | +$1.6M |
|
20
Akebia Therapeutics
AKBA
$833M
| $8.66M | 1.75% | 831,515 -113,064 | -12% | -$1.18M |
|
|
MRTX
21
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $7.16M | 1.45% | 1,508,201 +19,714 | +1% | +$93.6K |
|
|
SRNE
22
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $7.14M | 1.44% | 1,456,056 -75,217 | -5% | -$369K |
|
23
Veracyte
VCYT
$2.39B
| $7.02M | 1.42% | 906,999 -11,557 | -1% | -$89.4K |
|
|
24
Vanda Pharmaceuticals
VNDA
$279M
| $6.08M | 1.23% | 381,466 -446,227 | -54% | -$7.12M |
|
|
ALIM
25
DELISTED
Alimera Sciences, Inc.
ALIM
| $4.36M | 0.88% | 4,034,488 +459,488 | +13% | +$496K |
|